Filing a DMF for Terluran(R) HD-15 with the U.S. FDA
Filing a drug master file (DMF) for Terluran(R) HD-15 can be a useful mechanism to market your
Terluran(R) HD-15 to the U.S. Drug Industry. Typical Terluran(R) HD-15 producers who have filed a DMF for
Terluran(R) HD-15 include:
-
BASF Aktiengesellschaft
Registrar Corp can help you to properly prepare and submit your Terluran(R) HD-15 DMF to FDA.
As your Agent, Registrar Corp will perform the following administrative functions:
-
Format, assemble and deliver your Terluran(R) HD-15 DMF to FDA
-
Submit letters of authorization regarding your Terluran(R) HD-15 to FDA
-
Provide changes, additions and maintenance of your Terluran(R) HD-15 DMF
-
Respond to issues relating to ownership of your Terluran(R) HD-15 DMF
-
Assist with submission of responses to FDA concerning your Terluran(R) HD-15 DMF
-
Perform any required annual updates for your Terluran(R) HD-15 DMF
For more information about filing a DMF for Terluran(R) HD-15, simply click below:
U.S. FDA Regulations:
U.S. FDA DMF Regulation: 21 C.F.R. Section 314.420
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
